TY - JOUR AU - Bauduceau, B. AU - Floch, J. P. AU - Halimi, S. PY - 2018 DA - 2018// TI - Cardiovascular complications over 5 years and their association with survival in the GERODIAB cohort of elderly french patients with type 2 diabetes JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dc17-1437 DO - 10.2337/dc17-1437 ID - Bauduceau2018 ER - TY - JOUR AU - Shah, A. D. AU - Langenberg, C. AU - Rapsomaniki, E. PY - 2015 DA - 2015// TI - Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people JO - Lancet Diabetes Endocrinol. VL - 3 UR - https://doi.org/10.1016/S2213-8587(14)70219-0 DO - 10.1016/S2213-8587(14)70219-0 ID - Shah2015 ER - TY - JOUR AU - Stafeev, I. S. AU - Vorotnikov, A. V. AU - Ratner, E. I. PY - 2017 DA - 2017// TI - Latent inflammation and insulin resistance in adipose tissue JO - Int J Endocrinol. VL - 2017 UR - https://doi.org/10.1155/2017/5076732 DO - 10.1155/2017/5076732 ID - Stafeev2017 ER - TY - JOUR AU - Rehman, K. AU - Akash, M. S. H. PY - 2017 DA - 2017// TI - Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? JO - J Cell Biochem VL - 118 UR - https://doi.org/10.1002/jcb.26097 DO - 10.1002/jcb.26097 ID - Rehman2017 ER - TY - JOUR AU - Francisqueti, F. V. AU - Chiaverini, L. C. AU - Santos, K. C. PY - 2017 DA - 2017// TI - The role of oxidative stress on the pathophysiology of metabolic syndrome JO - Rev Assoc Med Bras VL - 63 UR - https://doi.org/10.1590/1806-9282.63.01.85 DO - 10.1590/1806-9282.63.01.85 ID - Francisqueti2017 ER - TY - JOUR AU - Evans, J. L. AU - Goldfine, I. A. AU - Maddux, B. A. PY - 2002 DA - 2002// TI - Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes JO - Endocrine Rev. VL - 23 UR - https://doi.org/10.1210/er.2001-0039 DO - 10.1210/er.2001-0039 ID - Evans2002 ER - TY - JOUR AU - Fernandez, M. AU - Triplitt, C. AU - Wajcberg, E. PY - 2008 DA - 2008// TI - Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc07-0711 DO - 10.2337/dc07-0711 ID - Fernandez2008 ER - TY - JOUR AU - Home, P. D. AU - Pocock, S. J. AU - Beck-Nielsen, H. PY - 2009 DA - 2009// TI - Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60953-3 DO - 10.1016/S0140-6736(09)60953-3 ID - Home2009 ER - TY - JOUR AU - Florez, H. AU - Reaven, P. D. AU - Bahn, G. PY - 2015 DA - 2015// TI - Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial JO - Diabetes Obes Metab VL - 17 UR - https://doi.org/10.1111/dom.12487 DO - 10.1111/dom.12487 ID - Florez2015 ER - TY - JOUR AU - Kavak, S. AU - Ayaz, L. AU - Emre, M. PY - 2012 DA - 2012// TI - Effects of rosiglitazone with insulin combination therapy on oxidative stress and lipid profile in left ventricular muscles of diabetic rats JO - Exp Diabetes Res. VL - 2012 UR - https://doi.org/10.1155/2012/905683 DO - 10.1155/2012/905683 ID - Kavak2012 ER - TY - JOUR AU - Lin, C. F. AU - Young, K. C. AU - Bai, C. H. PY - 2014 DA - 2014// TI - Rosiglitazone regulates anti-inflammation and growth inhibition via PTEN JO - Biomed Res Int VL - 2014 UR - https://doi.org/10.1155/2014/787924 DO - 10.1155/2014/787924 ID - Lin2014 ER - TY - JOUR AU - Zhang, Z. AU - Zhang, X. AU - Korantzopoulos, P. PY - 2017 DA - 2017// TI - Thiazolidinedione use and atrial fibrillation in diabetic patients:a meta-analysis JO - BMC Cardiovasc Disord VL - 17 UR - https://doi.org/10.1186/s12872-017-0531-4 DO - 10.1186/s12872-017-0531-4 ID - Zhang2017 ER - TY - JOUR AU - Malínská, H. AU - Oliyarnyk, O. AU - Škop, V. PY - 2016 DA - 2016// TI - Effects of metformin on tissue oxidative and dicarbonyl stress in transgenic spontaneously hypertensive rats expressing human C-reactive protein JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0150924 DO - 10.1371/journal.pone.0150924 ID - Malínská2016 ER - TY - JOUR AU - Pruski, M. AU - Krysiak, R. AU - Okopien, B. PY - 2009 DA - 2009// TI - Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc08-2335 DO - 10.2337/dc08-2335 ID - Pruski2009 ER - TY - JOUR AU - Kender, Z. AU - Fleming, T. AU - Kopf, S. PY - 2014 DA - 2014// TI - Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes JO - Exp Clin Endocrinol Diabetes VL - 122 UR - https://doi.org/10.1055/s-0034-1371818 DO - 10.1055/s-0034-1371818 ID - Kender2014 ER - TY - JOUR AU - Bailey, C. J. PY - 2005 DA - 2005// TI - Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones JO - Diabetes Obes Metab VL - 7 UR - https://doi.org/10.1111/j.1463-1326.2005.00497.x DO - 10.1111/j.1463-1326.2005.00497.x ID - Bailey2005 ER - TY - JOUR AU - Rodney, A. AU - Hayward, R. A. AU - Reaven, P. D. PY - 2015 DA - 2015// TI - Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1414266 DO - 10.1056/NEJMoa1414266 ID - Rodney2015 ER - TY - JOUR AU - Home, P. AU - Riddle, M. AU - Cefalu, W. T. PY - 2014 DA - 2014// TI - Insulin therapy in people with type 2 diabetes: opportunities and challenges? JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc13-2743 DO - 10.2337/dc13-2743 ID - Home2014 ER - TY - JOUR AU - Cicero, A. F. G. AU - Tartagni, E. AU - Ertek, S. PY - 2012 DA - 2012// TI - Metformin and its clinical use: new insights for an old drug in clinical practice JO - Arch Med Sci. VL - 8 UR - https://doi.org/10.5114/aoms.2012.31622 DO - 10.5114/aoms.2012.31622 ID - Cicero2012 ER - TY - JOUR AU - Yki-Järvinen, H. PY - 2004 DA - 2004// TI - Thiazolidinediones JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMra041001 DO - 10.1056/NEJMra041001 ID - Yki-Järvinen2004 ER - TY - JOUR AU - James, X. u. AU - Rajaratnam, R. o. h. a. n. PY - 2017 DA - 2017// TI - Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes JO - Cardiovasc Diabetol. VL - 16 UR - https://doi.org/10.1186/s12933-017-0499-5 DO - 10.1186/s12933-017-0499-5 ID - James2017 ER - TY - JOUR AU - Kern, P. A. AU - Ranganathan, S. AU - Li, C. PY - 2001 DA - 2001// TI - Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance JO - Am J Physiol Endocrinol Metab VL - 280 UR - https://doi.org/10.1152/ajpendo.2001.280.5.E745 DO - 10.1152/ajpendo.2001.280.5.E745 ID - Kern2001 ER - TY - JOUR AU - Engin, A. PY - 2017 DA - 2017// TI - ThePathogenesis of obesity-associated adipose tissue inflammation JO - Adv Exp Med Biol VL - 960 UR - https://doi.org/10.1007/978-3-319-48382-5_9 DO - 10.1007/978-3-319-48382-5_9 ID - Engin2017 ER - TY - JOUR AU - Kaptoge, S. AU - Seshasai, S. R. AU - Gao, P. PY - 2014 DA - 2014// TI - Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis JO - Eur Heart J VL - 35 UR - https://doi.org/10.1093/eurheartj/eht367 DO - 10.1093/eurheartj/eht367 ID - Kaptoge2014 ER - TY - JOUR AU - Esser, N. AU - Paquot, N. AU - Scheen, A. J. PY - 2015 DA - 2015// TI - Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease JO - Expert Opin Investig Drugs VL - 24 UR - https://doi.org/10.1517/13543784.2015.974804 DO - 10.1517/13543784.2015.974804 ID - Esser2015 ER - TY - JOUR AU - Assy, N. AU - Grozovski, M. AU - Bersudsky, I. PY - 2006 DA - 2006// TI - Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease JO - World J Gastroenterol VL - 21 UR - https://doi.org/10.3748/wjg.v12.i27.4369 DO - 10.3748/wjg.v12.i27.4369 ID - Assy2006 ER - TY - JOUR AU - Arai, M. AU - Uchiba, M. AU - Komura, H. PY - 2010 DA - 2010// TI - Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro JO - J Pharmacol Exp Ther VL - 334 UR - https://doi.org/10.1124/jpet.109.164970 DO - 10.1124/jpet.109.164970 ID - Arai2010 ER - TY - JOUR AU - Cullen, E. AU - Liao, J. AU - Lukacsko, P. PY - 2004 DA - 2004// TI - Pharmacokinetics and dose proportionality of extended—release metformin following administration of 1000, 1500, 2000, and 2500 mg in healthy volunteers JO - Biopharm Drug Dispos VL - 25 UR - https://doi.org/10.1002/bdd.407 DO - 10.1002/bdd.407 ID - Cullen2004 ER - TY - JOUR AU - Pal, M. AU - Febbraio, M. A. AU - Whitham, M. PY - 2014 DA - 2014// TI - From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation JO - Immunol Cell Biol VL - 92 UR - https://doi.org/10.1038/icb.2014.16 DO - 10.1038/icb.2014.16 ID - Pal2014 ER - TY - JOUR AU - Harder-Lauridsen, N. M. AU - Krogh-Madsen, R. AU - Holst, J. J. PY - 2014 DA - 2014// TI - Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes JO - Am J Physiol VL - 306 ID - Harder-Lauridsen2014 ER - TY - JOUR AU - Lowe, G. AU - Woodward, M. AU - Hillis, G. PY - 2014 DA - 2014// TI - Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study JO - Diabetes VL - 63 UR - https://doi.org/10.2337/db12-1625 DO - 10.2337/db12-1625 ID - Lowe2014 ER - TY - JOUR AU - Kadoglou, N. P. E. AU - Kapelouzou, A. AU - Tsanikidis, H. PY - 2011 DA - 2011// TI - Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes JO - Exp Clin Endocrinol Diabetes VL - 119 UR - https://doi.org/10.1055/s-0030-1265174 DO - 10.1055/s-0030-1265174 ID - Kadoglou2011 ER - TY - JOUR AU - Erem, C. AU - Ozbas, H. M. AU - Nuhoglu, I. PY - 2014 DA - 2014// TI - Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus JO - Exp Clin Endocrinol Diabetes VL - 122 UR - https://doi.org/10.1055/s-0034-1370989 DO - 10.1055/s-0034-1370989 ID - Erem2014 ER - TY - JOUR AU - Borowska, M. AU - Dworacka, M. AU - Wesołowska, A. PY - 2016 DA - 2016// TI - The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion JO - Pharmacology VL - 97 UR - https://doi.org/10.1159/000443897 DO - 10.1159/000443897 ID - Borowska2016 ER - TY - JOUR AU - Wang, J. AU - Zhu, L. AU - Hu, K. PY - 2017 DA - 2017// TI - Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis JO - Medicine (Baltimore). VL - 96 UR - https://doi.org/10.1097/MD.0000000000008183 DO - 10.1097/MD.0000000000008183 ID - Wang2017 ER - TY - JOUR AU - Besedovsky, H. O. AU - Rey, A. D. PY - 2014 DA - 2014// TI - Physiologic versus diabetogenic effects of interleukin- 1: a question of weight JO - Curr Pharm Des VL - 20 UR - https://doi.org/10.2174/1381612820666140130204401 DO - 10.2174/1381612820666140130204401 ID - Besedovsky2014 ER - TY - JOUR AU - Mooradian, A. D. AU - Reed, R. L. AU - Meredith, K. E. AU - Scuderi, P. PY - 1991 DA - 1991// TI - Serum levels of tumor necrosis factor and IL-1 alpha and IL-1 beta in diabetic patients JO - Diabetes Care VL - 14 UR - https://doi.org/10.2337/diacare.14.1.63 DO - 10.2337/diacare.14.1.63 ID - Mooradian1991 ER - TY - JOUR AU - Ohkuma, T. AU - Jun, M. AU - Woodward, M. PY - 2017 DA - 2017// TI - Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the Advance Trial JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc17-0509 DO - 10.2337/dc17-0509 ID - Ohkuma2017 ER - TY - JOUR AU - Kahn, S. E. AU - Haffner, S. M. AU - Viberti, G. PY - 2010 DA - 2010// TI - Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain JO - Diabetes Care VL - 33 UR - https://doi.org/10.2337/dc09-1661 DO - 10.2337/dc09-1661 ID - Kahn2010 ER - TY - JOUR AU - Takebayashi, K. AU - Aso, Y. AU - Inukai, T. PY - 2004 DA - 2004// TI - Initiation of insulin therapy reduces serum concentrations of high-sensitivity C- reactive protein in patients with type 2 diabetes JO - Metabolism. VL - 53 UR - https://doi.org/10.1016/j.metabol.2004.01.003 DO - 10.1016/j.metabol.2004.01.003 ID - Takebayashi2004 ER - TY - JOUR AU - Pradhan, A. D. AU - Everett, B. M. AU - Cook, N. R. PY - 2009 DA - 2009// TI - Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial JO - JAMA VL - 302 UR - https://doi.org/10.1001/jama.2009.1347 DO - 10.1001/jama.2009.1347 ID - Pradhan2009 ER - TY - JOUR AU - Khatana, S. A. AU - Taveira, T. H. AU - Dooley, A. G. PY - 2010 DA - 2010// TI - The association between C-reactive protein levels and insulin therapy in obese vs nonobese veterans with type 2 diabetes mellitus JO - J Clin Hypertens (Greenwich). VL - 12 UR - https://doi.org/10.1111/j.1751-7176.2010.00296.x DO - 10.1111/j.1751-7176.2010.00296.x ID - Khatana2010 ER - TY - JOUR AU - Huang, M. L. AU - Que, Y. Y. AU - Shen, X. P. PY - 2015 DA - 2015// TI - Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients JO - J Diabetes Compl VL - 29 UR - https://doi.org/10.1016/j.jdiacomp.2014.12.007 DO - 10.1016/j.jdiacomp.2014.12.007 ID - Huang2015 ER - TY - JOUR AU - He, H. AU - Tao, H. AU - Xiong, H. PY - 2014 DA - 2014// TI - Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptorγ-independent mitochondrial oxidative stress in mouse hearts JO - Toxicol Sci VL - 138 UR - https://doi.org/10.1093/toxsci/kfu015 DO - 10.1093/toxsci/kfu015 ID - He2014 ER - TY - JOUR AU - Calkin, A. C. AU - Forbes, J. M. AU - Smith, C. M. PY - 2005 DA - 2005// TI - Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects JO - Arterioscler Thromb Vasc Biol VL - 25 UR - https://doi.org/10.1161/01.ATV.0000177813.99577.6b DO - 10.1161/01.ATV.0000177813.99577.6b ID - Calkin2005 ER - TY - JOUR AU - Barroso, I. AU - Gurnell, M. AU - Crowley, V. E. PY - 1999 DA - 1999// TI - Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension JO - Nature VL - 402 UR - https://doi.org/10.1038/47254 DO - 10.1038/47254 ID - Barroso1999 ER - TY - JOUR AU - Grey, S. T. AU - Mackay, F. PY - 2007 DA - 2007// TI - Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype JO - Endocrinology VL - 148 UR - https://doi.org/10.1210/en.2006-0686 DO - 10.1210/en.2006-0686 ID - Grey2007 ER - TY - JOUR AU - Chen, Q. AU - Yu, W. AU - Shi, J. L. PY - 2014 DA - 2014// TI - Insulin alleviates the inflammatory response and oxidative stress injury in cerebral tissues in septic rats JO - J Inflamm (Lond) VL - 11 UR - https://doi.org/10.1186/1476-9255-11-18 DO - 10.1186/1476-9255-11-18 ID - Chen2014 ER - TY - JOUR AU - Paneni, F. AU - Beckman, J. A. AU - Creager, M. A. PY - 2013 DA - 2013// TI - Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/eht149 DO - 10.1093/eurheartj/eht149 ID - Paneni2013 ER - TY - JOUR AU - Nissen, S. E. AU - Wolski, K. PY - 2007 DA - 2007// TI - Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa072761 DO - 10.1056/NEJMoa072761 ID - Nissen2007 ER - TY - JOUR AU - LeRoith, D. AU - Biessels, G. J. AU - Braithwaite, S. S. PY - 2019 DA - 2019// TI - Treatment of diabetes in older adults: an endocrine society clinical practice guideline JO - J Clin Endocrinol Metab VL - 104 UR - https://doi.org/10.1210/jc.2019-00198 DO - 10.1210/jc.2019-00198 ID - LeRoith2019 ER -